Novavax Inc Sustainability Reports
Novavax, Inc. is a biotechnology company that discovers, develops, and commercializes innovative vaccines to prevent serious infectious diseases. The company utilizes a proprietary recombinant nanoparticle technology platform alongside its Matrix-M adjuvant to enhance immune responses.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900J4GJHPEPQ23205
FIGI: BBG001SGL8G3
13 reports from 2007 to 2024
